Time to rethink immunosuppression by mTOR inhibitors?

Nature Reviews Nephrology

Volumn 5, Issue 11, 2009, Pages 611-612

  Säemann, Marcus D ^a   Remuzzi, Giuseppe ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; RAPAMYCIN; TACROLIMUS; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; PROTEIN KINASE; PROTEIN KINASE INHIBITOR;

ACUTE GRAFT REJECTION; ADAPTIVE IMMUNITY; ALLOTRANSPLANTATION; BONE MARROW TOXICITY; CELL CYCLE REGULATION; CELL PROLIFERATION; ENZYME INHIBITION; GRAFT RECIPIENT; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; NEPHROTOXICITY; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; GRAFT REJECTION; NOTE; ORGAN TRANSPLANTATION; PHYSIOLOGY;

GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; SIROLIMUS;

EID: 70350495363     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2009.168     Document Type: Short Survey

References (10)

1. Araki, K. et al. mTOR regulates memory CD8 T-cell differentiation. Nature 460, 108-112 (2009).
2. Pearce, E. L. et al. enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460, 103-107 (2009).
3. Pallet, N., Thervet, E., Legendre, C. & Anglicheau D. sirolimus early graft nephrotoxicity: clinical and experimental data. Curr. Drug. Saf. 1, 179-187 (2006).
4. Ekberg, H. et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N. Engl. J. Med. 357, 2562-2575 (2007).
5. Barozzi, P. et al. Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma. Transplantation 86, 738-744 (2008).
6. Demopoulos, L. et al. Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials. Transplant. Proc. 40, 1407-1410 (2008).
7. Jagannath, C. et al. Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat. Med. 15, 267-276 (2009).
8. weichhart, T. et al. The TsC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29, 565-577 (2008).
9. Delgoffe, G. M. et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30, 832-844 (2009).
10. Ruggenenti, P. et al. sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury. Transplantation 84, 956-964 (2007).